A Dark Vector Cognition product

Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

None.

​

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Bolingbrook, State of Illinois, on March 26, 2026.

​​​
​ULTA BEAUTY, INC.
​​​
​By:/s/ Christopher Lialios
​​Christopher Lialios
​​Senior Vice President Controller (Principal Accounting Officer)
​​​

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

​​​​​
Signatures​Title​Date
​​​​​
/s/ Kecia L. Steelman​President and Chief Executive Officer​March 26, 2026
Kecia L. Steelman​and Director (Principal Executive Officer)​​
​​​​​
/s/ Christopher J. DelOrefice​Chief Financial Officer​March 26, 2026
Christopher J. DelOrefice​(Principal Financial Officer)​​
​​​​​
/s/ Christopher Lialios​Senior Vice President Controller​March 26, 2026
Christopher Lialios​(Principal Accounting Officer)​​
​​​​​
/s/ Martin Brok​Director​March 26, 2026
Martin Brok​​​​
​​​​​
/s/ Michelle L. Collins​Director​March 26, 2026
Michelle L. Collins​​​​
​​​​​
/s/ Kelly E. Garcia​Director​March 26, 2026
Kelly E. Garcia​​​​
​​​​​
/s/ Catherine Halligan​Director​March 26, 2026
Catherine Halligan​​​​
​​​​​
/s/ Stephenie Landry​Director​March 26, 2026
Stephenie Landry​​​​
​​​​​
/s/ Patricia A. Little​Director​March 26, 2026
Patricia A. Little​​​​
​​​​​
/s/ George Mrkonic​Director​March 26, 2026
George Mrkonic​​​​
​​​​​
/s/ Lorna E. Nagler​Non-Executive Chair of the Board of​March 26, 2026
Lorna E. Nagler​Directors​​
​​​​​
/s/ Heidi G. Petz​Director​March 26, 2026
Heidi G. Petz​​​​
​​​​​
/s/ Gisel Ruiz​Director​March 26, 2026
Gisel Ruiz​​​​
​​​​​
/s/ Michael C. Smith​Director​March 26, 2026
Michael C. Smith​​​​

​

​

Previous: Item 15. Exhibits and Financial Statement Schedules